Lessons learned from detecting and responding to recurrent measles outbreak in Liberia post Ebola-Epidemic 2016-2017.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2019
Historique:
received: 23 09 2018
accepted: 15 04 2019
entrez: 13 8 2019
pubmed: 14 8 2019
medline: 7 9 2019
Statut: epublish

Résumé

Measles is an acute viral disease that remains endemic in much of sub-Sahara Africa, including Liberia. The 2014 Ebola epidemic disrupted an already fragile health system contributing to low uptake of immunization services, population immunity remained low thus facilitating recurrent outbreaks of measles in Liberia. We describe lessons learnt from detecting and responding to recurrent outbreaks of measles two years post the 2014 Ebola epidemic in Liberia. We conducted a descriptive study using the findings from Integrated Diseases Surveillance and Response (IDSR) 15 counties, National Public Health Institute of Liberia (NPHIL), National Public Health Reference Laboratory (NPHRL) and District Health Information Software (DIHS2) data conducted from October to December, 2017. We perused the outbreaks line lists and other key documents submitted by the counties to the national level from January 2016 to December 2017. From January 2016 to December 2017, 2,954 suspected cases of measles were reported through IDSR. Four hundred sixty-seven (467) were laboratory confirmed (IgM-positive), 776 epidemiologically linked, 574 clinically confirmed, and 1,137 discarded (IgM-negative). Nine deaths out of 1817 cases were reported, a case fatality rate of 0.5%; 49% were children below the age of 5 years. Twenty-two percent (405/1817) of the confirmed cases were vaccinated while the vaccination status of 55% (994/1817) was unknown. Revitalization of IDSR contributed to increased detection and reporting of suspected cases of measles thus facilitating early identification and response to outbreaks. Priority needs to be given to increasing the uptake of routine immunization services, introducing a second dose of measles vaccine in the routine immunization program and conducting a high-quality supplementary measles immunization campaign for age group 1 to 10 years to provide protection for a huge cohort of susceptible.

Identifiants

pubmed: 31402966
doi: 10.11604/pamj.supp.2019.33.2.17172
pii: PAMJ-SUPP-33-2-07
pmc: PMC6675928
doi:

Substances chimiques

Measles Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Pediatr Infect Dis J. 2003 Aug;22(8):691-5
pubmed: 12913768
Asian Pac J Trop Med. 2013 Feb;6(2):131-4
pubmed: 23339915
Online J Public Health Inform. 2016 Nov 28;8(3):e206
pubmed: 28210427
PLoS One. 2017 Sep 8;12(9):e0184549
pubmed: 28886171
PLoS Curr. 2017 Nov 9;9:
pubmed: 29188127

Auteurs

Thomas Nagbe (T)

National Public Health Institute, Monrovia, Liberia.

George Sie Williams (GS)

World Health Organization, Monrovia, Liberia.

Julius Monday Rude (JM)

World Health Organization, Monrovia, Liberia.

Sumor Flomo (S)

National Public Health Institute, Monrovia, Liberia.

Trokon Yeabah (T)

National Public Health Institute, Monrovia, Liberia.

Mosoka Fallah (M)

National Public Health Institute, Monrovia, Liberia.

Laura Skrip (L)

National Public Health Institute, Monrovia, Liberia.

Chukwuemeka Agbo (C)

World Health Organization, Monrovia, Liberia.

Nuha Mahmoud (N)

World Health Organization, Monrovia, Liberia.

Joseph Chukwudi Okeibunor (JC)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Kwuakuan Yealue (K)

World Health Organization, Monrovia, Liberia.

Ambrose Talisuna (A)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Ali Ahmed Yahaya (AA)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Soatiana Rajatonirina (S)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Adolphus Clarke (A)

Ministry of Health, Monrovia, Liberia.

Esther Hamblion (E)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Tolbert Nyenswah (T)

National Public Health Institute, Monrovia, Liberia.

Bernice Dahn (B)

Ministry of Health, Monrovia, Liberia.

Alex Gasasira (A)

World Health Organization, Monrovia, Liberia.

Ibrahima Socé Fall (IS)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH